Not recruiting
Optic glioma
Not recruitingStudy on the Safety and Effectiveness of Nerve Growth Factor CHF6467 for Children and Young Adults with Optic Pathway Glioma
Investigational
Study on the Safety and Effectiveness of Nerve Growth Factor CHF6467 for Children and Young Adults with Optic Pathway Glioma
Investigational
- Disease:Optic glioma
- Substances:Nerve growth factor, recombinant (R100E)
Countries:
Italy
Italy- Participants:0–17 years · 18–64 years
- Substances:Nerve growth factor, recombinant (R100E)
